Saturday 17 October 2026 Export AMRX’s income statement to Excel — free account

AMNEAL PHARMACEUTICALS, INC.

AMRX Healthcare Drug Manufacturers Specialty & Generic

AMNEAL PHARMACEUTICALS, INC.’s revenue for fiscal 2025 (year ended December 2025) was $3.0 billion, up 8.05% from fiscal 2024. In the quarter to June 2026, revenue grew 9.89%, EPS grew 157.1%, free cash flow fell 351.4% and total debt rose 8.22%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

19.18 0.07 −0.36%

Follow AMRX

Alert me

Market cap: $6.2B
P/E: 38.4×
Fwd P/E: 51.6×
Dividend yield: —
F-score: 7/9
Altman Z: 1.94
Beneish M: −2.68
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	34.62	31.87	54.78	500.50	+8 more quarters Free account
P/S ratio Full definition →	1.77	1.29	1.31	1.07
P/FCF ratio Full definition →	0.00	20.71	17.34	13.22
P/Operating CF Full definition →	(260.09)	(146.89)	30.30	26.55
P/B ratio Full definition →	167.31	0.00	0.00	0.00
Price to Tangible BV Full definition →	0.00	0.00	0.00	0.00
EV/Sales Full definition →	2.59	2.09	2.06	1.87
EV/EBITDA Full definition →	12.12	9.60	9.70	8.79
EV/Operating CF Full definition →	40.14	20.77	18.26	16.73
EV/FCF Full definition →	(695.25)	33.50	27.27	23.05
Quick Ratio Full definition →	1.31	1.45	1.37	1.30
Current Ratio Full definition →	2.20	2.47	2.17	2.13
Net Debt/EBITDA Full definition →	13.95	12.84	13.71	18.06
Debt/Assets Full definition →	70.71%	74.19%	69.92%	71.49%
Debt/Equity Full definition →	80.86	(57.14)	(36.06)	(23.41)
Asset Turnover Full definition →	0.87	0.88	0.84	0.83
Operating CF/Net income Full definition →	(0.37)	(0.43)	3.72	50.00
Capex/Depreciation Full definition →	(2.37)	(0.46)	(0.86)	(0.38)
Interest Coverage Full definition →	2.36	2.66	1.99	1.12
Research and Development Expense of Revenue Full definition →	4.90%	5.31%	4.28%	8.08%
Selling, General and Administrative Expense of Revenue Full definition →	18.68%	19.22%	17.99%	17.57%
Intangible Assets out of Total Assets Full definition →	0.31	0.32	0.32	0.33
Share Based Compensation of Revenue Full definition →	1.31%	1.22%	1.01%	1.05%
Graham Net Nets Full definition →	(0.33)	(0.46)	(0.47)	(0.60)
Graham Number Full definition →	1.08	0.00	0.00	0.00
Earnings Yield Full definition →	2.89%	3.14%	1.83%	0.20%
Free Cash Flow Yield Full definition →	(0.21%)	4.83%	5.77%	7.56%
Revenue per Share Full definition →	2.49	2.29	2.60	2.50
Operating CF per Share Full definition →	(0.07)	(0.08)	0.42	0.38
Capex per Share Full definition →	(0.38)	(0.07)	(0.15)	(0.07)
Free Cash Flow per Share Full definition →	(0.45)	(0.15)	0.27	0.31
Cash per Share Full definition →	0.43	0.64	0.99	0.75
Shareholders Equity per Share Full definition →	0.10	(0.15)	(0.23)	(0.35)
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	0.10	(0.15)	(0.23)	(0.35)
Free Cash Flow Full definition →	(143.99)	(48.45)	84.86	95.99
Working Capital Full definition →	1,063.84	1,069.86	1,029.55	976.37
Capital Expenditures Full definition →	(122.74)	(21.71)	(45.45)	(22.46)
Net Current Asset Value Full definition →	(1,796.29)	(1,788.28)	(1,838.43)	(1,871.35)
EV/EBIT Full definition →	17.76	14.59	15.76	15.32
Capex to Sales Full definition →	0.15	0.03	0.06	0.03
Price to Operating Income Full definition →	12.17	9.02	10.02	8.79
Other line items
Average Receivables Full definition →	915.01	803.05	835.91	821.56
Average Payables Full definition →	694.01	645.77	748.38	701.46
Average Inventory Full definition →	643.46	621.53	609.38	605.43
Average Assets Full definition →	3,599.57	3,452.73	3,589.86	3,530.43
Average Common Equity Full definition →	(39.75)	(88.98)	(90.42)	(101.76)

Show all line items

Columns are period end dates

Stockrow Weekly